The genes sharing these GO terms have been previously shown to be involved in breast cancer prognostic process (e.g., CXCR6, KIT, RUNX3) and also immune cell regulation (e.g., CD8B, DAPP1, LY75). This evidence concerns the gene CXCR6 and breast carcinoma.